| Schedule of commitments given and received |
| | | | | In thousands of euros | | Dec. 31, 2024 | | June 30, 2025 | CRO (1) | | 156,870 | | 181,617 | CMO | | 5,332 | | 5,810 | Lease | | 6,570 | | 5,622 | Others | | 18,476 | | 27,132 | Total commitments given | | 187,248 | | 220,180 | Agreements concerning the provision of facilities | | 326 | | 354 | Total commitments received | | 326 | | 354 |
(1)Including CRO with Pharmaceutical Research Associates B.V.
|
| Schedule of maturity analysis of financial liabilities |
| | | | | | | | | June 30, 2025 | | | | Between 1 and | | Between 3 and | | | (in thousands of euros) | | Less than 1 year | | 3 years | | 5 years | | More than 5 years | Bank borrowings and related derivatives | | 2,966 | | 58,580 | | 1,780 | | — | Accrued interest payable on loans | | 8 | | 2,163 | | — | | — | Lease liabilities | | 2,608 | | 1,405 | | — | | — | Royalty certificates liabilities | | — | | 1,383 | | 21,225 | | 399,865 | Trade payables | | 34,703 | | — | | — | | — | Other miscellaneous payables | | 4,611 | | — | | — | | — | Total debt | | 44,896 | | 63,531 | | 23,005 | | 399,865 |
| | | | | | | | | Dec. 31, 2024 | | | | Between 1 and | | Between 3 and | | | In thousands of euros | | Less than 1 year | | 3 years | | 5 years | | More than 5 years | Bank borrowings | | 3,275 | | 39,252 | | 2,002 | | 668 | Accrued interest payable on loans | | 73 | | 1,816 | | — | | — | Lease liabilities | | 2,642 | | 2,330 | | 4 | | — | Royalty certificates liabilities | | — | | — | | — | | 422,472 | Trade payables | | 32,862 | | — | | — | | — | Other miscellaneous payables | | 331 | | — | | — | | — | Total debt | | 39,184 | | 43,398 | | 2,006 | | 423,140 |
|